Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2021 · 10-Q
Revenue$3.41M$3.41M+37.7% vs Q2 2020 Net Income-$3.74M-$3.74MN/M vs Q2 2020 EPS Diluted-$0.17-$0.17N/M vs Q2 2020 Gross Profit$2,274,000+35.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,718,000N/M Free Cash Flowderived-$3,683,000— Margins · derivedGross margin66.6%−1.0 pt vs Q2 2020
Operating margin-99.8%−40.3 pt vs Q2 2020
Net margin-109.7%−42.6 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end